Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Vertex Pharmaceuticals Incorporated”

980 pharma patents match "Vertex Pharmaceuticals Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 980
Index total 30,257
Page 31 / 41

Quick answer

This filtered view shows 980 pharmaceutical patents matching "Vertex Pharmaceuticals Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

980 results for “Vertex Pharmaceuticals Incorporated” · 30,257 patents in full index Clear search

  1. US 7691853

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted
  2. US 7691885

    Pyridones useful as inhibitors of kinases

    Vertex Pharmaceuticals Incorporated · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted
  3. US 7691902

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted
  4. US 7683065

    Pyridines useful as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Mar 23, 2010 · Expires Mar 18, 2030

    granted
  5. US 7683083

    Biphenyl derivatives as modulators of voltage gated ion channels

    Vertex Pharmaceuticals Incorporated · Granted Mar 23, 2010 · Expires Mar 18, 2030

    granted
  6. US 7683066

    Isoquinolines useful as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Mar 23, 2010 · Expires Mar 18, 2030

    granted
  7. US 7683033

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated · Granted Mar 23, 2010 · Expires Mar 18, 2030

    granted
  8. US 7678802

    Quinazolines useful as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Mar 16, 2010 · Expires Mar 11, 2030

    granted
  9. US 7671221

    Modulators of ATP-Binding Cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Mar 2, 2010 · Expires Feb 25, 2030

    granted
  10. US 7666647

    Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes

    Vertex Pharmaceuticals Incorporated · Granted Feb 23, 2010 · Expires Feb 18, 2030

    granted
  11. US 7659283

    Pyrrolo [3,2-C] pyridines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Feb 9, 2010 · Expires Feb 4, 2030

    granted
  12. US 7659268

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Feb 9, 2010 · Expires Feb 4, 2030

    granted
  13. US 7659309

    Polymorphic forms of (1-{3-[3-(4-cyano-3-methoxy-phenyl) ureido]-phenyl}-ethyl)-carbamic acid-2-cyano-1-ethyl-ethyl ester

    Vertex Pharmaceuticals Incorporated · Granted Feb 9, 2010 · Expires Feb 4, 2030

    granted
  14. US 7652153

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jan 26, 2010 · Expires Jan 21, 2030

    granted
  15. US 7652135

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Jan 26, 2010 · Expires Jan 21, 2030

    granted
  16. US 7645775

    Triazoles useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Jan 12, 2010 · Expires Jan 7, 2030

    granted
  17. US 7645789

    Indole derivatives as CFTR modulators

    Vertex Pharmaceuticals Incorporated · Granted Jan 12, 2010 · Expires Jan 7, 2030

    granted
  18. US 7625913

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Dec 1, 2009 · Expires Nov 26, 2029

    granted
  19. US 7622463

    Dihydrodiazepines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Nov 24, 2009 · Expires Nov 19, 2029

    granted
  20. US 7612091

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted
  21. US 7612065

    Inhibitors of c-JUN N-terminal kinases (JNK)

    Vertex Pharmaceuticals Incorporated · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted
  22. US 7608632

    Sulfonamide inhibitors of aspartyl protease

    Vertex Pharmaceuticals Incorporated · Granted Oct 27, 2009 · Expires Oct 22, 2029

    granted
  23. US 7605270

    Polymorphic forms of (S).-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) benzylcarbamate

    Vertex Pharmaceuticals Incorporated · Granted Oct 20, 2009 · Expires Oct 15, 2029

    granted
  24. US 7605174

    Indane derivatives as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Oct 20, 2009 · Expires Oct 15, 2029

    granted